ICON Selected by Shire plc’s Specialty Pharmaceuticals Division as Global Strategic Partner for Clinical Research and Central Laboratory Services

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that is has signed a strategic partnership with Shire Specialty Pharmaceuticals to serve as the sole global provider of central laboratory services and one of two strategic partners for clinical development services.